EMPA-KIDNEY Results Meeting - Agenda
FRIDAY 9 december 2022
| 12:00 - 14:00 | Registration and buffet lunch | |
| 14:00 - 14:10 | Introduction and welcome | Rory Collins (CTSU, Oxford) |
| 14:10 - 14:40 | Is medical management of obesity finally coming of age? | John Wilding (Liverpool) |
| 14:40 - 15:10 | PCSK9 synthesis inhibition with inclisiran: ORION-4 trial update | Louise Bowman (CTSU, Oxford) |
| 15:10 - 15:30 | Asymptomatic carotid disease: pills, surgery or stents? | Richard Bulbulia (CTSU, Oxford) |
| 15:30 - 15:35 | Discussion | |
| 15:35 - 16:10 | Break | |
| 16:10 - 16:25 | Detecting atrial fibrillation in older adults: AMALFI trial update |
Guilherme Pessoa-Amorim (CTSU, Oxford) |
| 16:25 - 16:40 | Fenofibrate for diabetic eye disease: LENS trial update | David Preiss (CTSU, Oxford) |
| 16:40 - 17:10 | Treatment for patients hospitalised with COVID-19: the RECOVERY trial |
Martin Landray (CTSU, Oxford) |
| 17:10 - 17:15 | Discussion | |
| 19:00 - 20:00 | Drinks reception | |
| 20:00 | Dinner |
saturday 10 december 2022
| 07:00 - 08:45 | Breakfast | |
| 08:40 - 09:00 | Registration | |
09:00 - 09:30 |
Cardiovascular protection with salt substitute: the Salt Substitute and Stroke Study |
Bruce Neal |
| 09:30 - 10:00 | TESTING steroids in IgA nephropathy |
Vlado Perkovic |
| 10:00 - 10:20 |
SGLT2 inhibition in chronic kidney disease: EMPA-KIDNEY trial update Baseline paper | Baseline supplementary info | SLGT-21 meta analysis |
Will Herrington (CTSU, Oxford) |
| 10:20 - 10:25 | Discussion | |
| 10:25 - 11:00 | Break | |
| 11:00 - 11:20 | The Cholesterol Treatment Triallists’ Collaboration: a mega IPD meta-analysis project to reliably assess all statin effects | Kirsty Reith (CTSU, Oxford) |
| 11:20 - 11:55 | Tabulations and tribulations: reflections from a DMC chair | Peter Sandercock (Edinburgh) |
| 11:55 - 12:00 | Discussion and close | |
| 12:00 - 13:00 | Lunch |